+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 0 - 18Years
All Genders
ID04190849

European Registry for Children Under 18 With Non-Alcoholic Fatty Liver Disease Long-Term Follow-Up to Understand Disease Progression and Outcomes

Led by Cambridge University Hospitals NHS Foundation Trust · Updated on 2022-03-04

2000

Participants Needed

3

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

The European Paediatric Non-Alcoholic Fatty Liver Disease Registry EU-PNAFLD brings together European centers caring for children with NAFLD, including hepatologists, endocrinologists, and scientists. This collaboration builds on existing databases and biorepositories, aligning with adult NAFLD registries to enable long-term follow-up and translational research. The study aims to support multi-center clinical trials, deepen understanding of NAFLD mechanisms, and establish the natural history of pediatric NAFLD. This observational registry includes children under 18 years diagnosed with NAFLD confirmed by imaging showing increased liver fat and excluding other causes. Diagnoses may also involve liver histology. The registry collects data over a long-term period, with up to 30 years of follow-up to monitor survival and disease progression. Participants will be followed longitudinally to assess outcomes such as survival, cardiovascular and liver morbidity, and asymptomatic liver disease progression. Data will come from clinical records, imaging, and laboratory results collected as part of routine care. This approach provides insight into the long-term impact of NAFLD in children and supports future research efforts.

CONDITIONS

Brief Title

European Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD)

Research Team

J

Jake P Mann, MRCPCH

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here